11/04/2014 - 12:22pm

The Iowa Board of Pharmacy is revisiting advocating the medical use of marijuana to state legislators.

11/03/2014 - 10:25am

Protein Sciences Corp. last week announced that the Food and Drug Administration approved Flublok influenza vaccine for all adults ages 18 years and older.

10/31/2014 - 12:15pm

Treasury Department aide Alastair “Al” Fitzpayne has been tapped as the Department of Health and Human Services’ next chief of staff, the Wall Street Journal reported.

10/30/2014 - 11:54am

AstraZeneca on Thursday announced that the Food and Drug Administration approved Xigduo XR (dapagliflozin and metformin hydrochloride extended-release), a once-daily drug for the treatment of adults with Type 2 diabetes. 

10/27/2014 - 10:16am

The National Association of Drug Diversion Investigators on Friday highlighted the latest results achieved by Alabama's real-time, stop-sale pseudoephedrine tracking system.

10/24/2014 - 8:57am

Pfizer on Thursday announced that the U.S. District Court for the District of Delaware upheld its basic patent and the L-malate salt patent covering Sutent (sunitinib malate) capsules.

10/22/2014 - 1:50pm

The Food and Drug Administration last week announced plans to survey pharmacists and patients about their experiences resulting from changes in generic drug pill appearance.

10/22/2014 - 11:20am

Pfizer last week announced that the Food and Drug Administration approved a revised label for Embeda (morphine sulfate and naltrexone hydrochloride) extended-release capsules, for oral use, CII, to include abuse-deterrence studies. 

 

10/22/2014 - 8:06am

A JAMA study noted that about two-thirds of dietary supplements recalled by the Food and Drug Administration still contained banned ingredients at least six months after being recalled.